Applied Finance Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Sell
6,845
-2,188
-24% -$749K 0.18% 68
2026
Q1
$3.18M Sell
9,033
-213
-2% -$75.9K 0.24% 61
2025
Q4
$3.03M Buy
9,246
+3,069
+50% +$974K 0.22% 63
2025
Q3
$1.74M Sell
6,177
-187
-3% -$54.2K 0.12% 70
2025
Q2
$1.78M Sell
6,364
-2,578
-29% -$730K 0.12% 76
2025
Q1
$2.79M Buy
8,942
+1,860
+26% +$549K 0.2% 60
2024
Q4
$1.85M Buy
7,082
+227
+3% +$67.3K 0.08% 67
2024
Q3
$2.21M Sell
6,855
-740
-10% -$242K 0.09% 61
2024
Q2
$2.37M Buy
+7,595
New +$2.23M 0.11% 58

Other funds holding AMGN

Applied Finance Capital Management's AMGN Position: Q2 2026 in Review

Applied Finance Capital Management reduced its Amgen (AMGN) stake by 24% in Q2 2026, selling an estimated $749K and leaving 6,845 shares worth $2.48M. The position accounts for 0.18% of the portfolio, ranked #68.

Applied Finance Capital Management first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.18M in Q1 2026. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Applied Finance Capital Management held 6,845 shares of Amgen worth $2.48M as of Q2 2026.
  • Applied Finance Capital Management sold 2,188 Amgen shares in Q2 2026, an estimated $749K.
  • Amgen made up 0.18% of Applied Finance Capital Management's portfolio in Q2 2026, its #68 holding.
  • Applied Finance Capital Management first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • Applied Finance Capital Management's Amgen position peaked at $3.18M in Q1 2026.
  • 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.